Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
August 11 2021 - 4:05PM
Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"),
a New Jersey based generics pharmaceutical company, today
announced they will hold a conference call at 8:30AM
ET on Monday, August 16th, 2021 to discuss the
second quarter ended June 30, 2021 financial results
and business update.
Conference Call InformationDate: Monday,
August 16, 2021Time: 8:30 a.m. Eastern TimeDial-in numbers:
Toll Free: 877-407-0792 International: 201-689-8263Conference
ID: 13721972
This call is available via webcast and can be accessed under
News & Events in the Investor Relations section
of Teligent, Inc.'s website at www.teligent.com.
About Teligent, Inc.Teligent is a
specialty generic pharmaceutical company. Our mission is to be a
leading player in the specialty generic prescription drug market.
Learn more on our website www.teligent.com.
Forward-Looking StatementsThis press release
includes certain “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, but are not limited to, plans,
objectives, expectations and intentions, and other statements
contained in this press release that are not historical facts and
statements identified by words such as “plan,” “believe,”
“continue,” “should” or words of similar meaning. Factors that
could cause actual results to differ materially from these
expectations include, but are not limited to: our inability to meet
current or future regulatory requirements in connection with
existing or future ANDAs; our inability to achieve profitability;
our failure to obtain FDA approvals as anticipated; our inability
to execute and implement our business plan and strategy; the
potential lack of market acceptance of our products; our inability
to protect our intellectual property rights; changes in global
political, economic, business, competitive, market and regulatory
factors; and our inability to successfully complete future product
acquisitions. These statements are based on our current beliefs or
expectations and are inherently subject to various risks and
uncertainties, including those set forth under the caption “Risk
Factors” in Teligent, Inc.’s most recent Annual Report on Form
10-K, Quarterly Reports on Form 10-Q and other periodic reports we
file with the Securities and Exchange
Commission. Teligent, Inc. does not undertake any
obligation to update any forward-looking statements contained in
this document as a result of new information, future events or
otherwise, except as required by law.
Contact:Philip YachmetzTeligent, Inc.(856)
776-4632pyachmetz@teligent.comwww.teligent.com
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Jul 2023 to Jul 2024